# Fiber Tolerability in Children

> **NCT02519374** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 40 (actual)

## Conditions studied

- Signs and Symptoms, Digestive

## Interventions

- **DRUG:** Placebo (including Maltodextrin)
- **DRUG:** PROMITOR® (including Maltodextrin)
- **DRUG:** PROMITOR® (including Maltodextrin)
- **DRUG:** PROMITOR® (including Maltodextrin)

## Key facts

- **NCT ID:** NCT02519374
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02519374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02519374, "Fiber Tolerability in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02519374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*